Dassault Systèmes to acquire ArisGlobal in up to USD2bn deal

Scancell and Neuphoria agree merger

Nona Biosciences agrees research collaboration with Medical University of Vienna to advance fully human antibody development for infectious diseases

GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC

Greenwich LifeSciences secures UK approval to expand Phase III breast cancer trial

Arrowhead reports positive Phase 3 results for plozasiran in severe hypertriglyceridaemia

Ipsen completes Memo Therapeutics acquisition to strengthen rare disease pipeline

Hugel Aesthetics expands US presence

WuXi AppTec named to FTSE4Good Index Series for fourth consecutive year

European Commission expands Crysvita approval to infants with XLH

Akagera Medicines reports positive first-in-human data for AKG-100

Argo Biopharma doses first participant in Phase I trial of factor XI targeting siRNA therapy

Acadia Pharmaceuticals announces receipt of FDA Fast Track designation for remlifanserin to treat Alzheimer's disease psychosis

Almirall advances Ebglyss paediatric regulatory filing in Europe

Sareum completes dosing in Phase 2-enabling toxicology programme for SDC-1801